Literature DB >> 26068657

New Hypertension Guidelines: Progression or a Step Backwards in Hypertension?

Markus van der Giet1, Markus Tölle.   

Abstract

In the last years, many hypertension guidelines have been published as new or revised versions. They follow the general trend that only clinical evidence is relevant for guidelines. Expert opinion is downplayed. At present, guidelines from three major organizations have been produced: by the European Society of Hypertension, the International Society/American Society of Hypertension, and the US Joint National Committee. We discuss eight versions of these guidelines in this review. All of these include statements on blood pressure goals or treatment algorithms for patients with high blood pressure. The variability of practical tips is great, and the recommendations, which mainly rely on evidence-based medical information, show slight differences that have resulted in some confusion with specialists and also practitioners. In the current review, the changes in the guidelines in comparison to previous guidelines are discussed, and reasons for different recommendations are explained. The hope is to reduce confusion.

Entities:  

Mesh:

Year:  2015        PMID: 26068657     DOI: 10.1007/s11906-015-0565-x

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  39 in total

1.  Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults.

Authors:  Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

2.  2014 Eighth Joint National Committee panel recommendation for blood pressure targets revisited: results from the INVEST study.

Authors:  Sripal Bangalore; Yan Gong; Rhonda M Cooper-DeHoff; Carl J Pepine; Franz H Messerli
Journal:  J Am Coll Cardiol       Date:  2014-08-26       Impact factor: 24.094

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals.

Authors:  Brent M Egan; Jiexiang Li; Florence N Hutchison; Keith C Ferdinand
Journal:  Circulation       Date:  2014-10-20       Impact factor: 29.690

Review 5.  The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Kaberi Dasgupta; Robert R Quinn; Kelly B Zarnke; Doreen M Rabi; Pietro Ravani; Stella S Daskalopoulou; Simon W Rabkin; Luc Trudeau; Ross D Feldman; Lyne Cloutier; Ally Prebtani; Robert J Herman; Simon L Bacon; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Mark Gelfer; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Kevin D Burns; Robert J Petrella; Swapnil Hiremath; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Milan Khara; Andrew Pipe; Paul Oh; Peter Selby; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Raj S Padwal; Luc Poirier
Journal:  Can J Cardiol       Date:  2014-02-22       Impact factor: 5.223

Review 6.  Beta-blockers for hypertension.

Authors:  Charles Shey Wiysonge; Hazel A Bradley; Jimmy Volmink; Bongani M Mayosi; Anthony Mbewu; Lionel H Opie
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

7.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

8.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

9.  2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.

Authors:  Chern-En Chiang; Tzung-Dau Wang; Kwo-Chang Ueng; Tsung-Hsien Lin; Hung-I Yeh; Chung-Yin Chen; Yih-Jer Wu; Wei-Chuan Tsai; Ting-Hsing Chao; Chen-Huan Chen; Pao-Hsien Chu; Chia-Lun Chao; Ping-Yen Liu; Shih-Hsien Sung; Hao-Min Cheng; Kang-Ling Wang; Yi-Heng Li; Fu-Tien Chiang; Jyh-Hong Chen; Wen-Jone Chen; San-Jou Yeh; Shing-Jong Lin
Journal:  J Chin Med Assoc       Date:  2014-12-26       Impact factor: 2.743

10.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Authors:  Paolo Verdecchia; Jan A Staessen; Fabio Angeli; Giovanni de Simone; Augusto Achilli; Antonello Ganau; Gianfrancesco Mureddu; Sergio Pede; Aldo P Maggioni; Donata Lucci; Gianpaolo Reboldi
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

View more
  1 in total

1.  A 10-year follow-up study of the association between calcium channel blocker use and the risk of dementia in elderly hypertensive patients.

Authors:  Chia-Liang Wu; Shu-Hui Wen
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.